Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A preliminary study on the changes of fecal short chain fatty acids in patients with traumatic spinal cord injury in the chronic phase

Abstract

Study design

Cross-sectional explorative observational study.

Setting

The China Rehabilitation Research Center is one of the centers for spinal cord injury in China, and this study investigates the Chinese part of spinal cord injury.

Objective

To observe the changes of fecal short-chain fatty acids (SCFA) in patients with traumatic spinal cord injury (TSCI) compared with normal controls.

Methods

Thirty-eight patients with TSCI who were hospitalized in Beijing Boai Hospital of China Rehabilitation Research Center from April, 2017 to October, 2018 were recruited. Basic data such as age, gender, neurological level, etiology, and defecation method were recorded, and neurogenic bowel dysfunction score (NBD) was assessed. Twenty-one healthy subjects from the staffs of Beijing Bo’ai Hospital were recruited as the control group. Fresh stool samples were collected and gas chromatography–mass spectrometry (GC-MS) was used to determine the contents of caproic acid, isovaleric acid, isobutyric acid, valeric acid, butyric acid, propionic acid and acetic acid in feces of TSCI patients and controls. The Mann-Whitney U test was used to compare SCFA levels between the two groups.

Results

Compared with healthy controls, the levels of isovaleric acid and isobutyric acid in the feces of TSCI patients increased, while the levels of butyric acid and acetic acid decreased, and the differences were statistically significant (P < 0.05).

Conclusion

The fecal content of propionic acid and butyric acid decreased while that of isobutyric acid and isoamyl acid increased in patients with chronic TSCI.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Data availability

The datasets used during the current study are available from the corresponding author upon reasonable request.

References

  1. GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:56–87.

    Article  Google Scholar 

  2. Mohammadi E, Villeneuve LM, Smith ZA. Spinal cord injury: the global incidence, prevalence, and disability from the global burden of disease study 2019. Spine. 2023;48:1767.

    PubMed  Google Scholar 

  3. Hu S, Wang P, Dong Y, Li F. Incidence, prevalence and disability of spinal cord injury in China from 1990 to 2019: a systematic analysis of the global burden of disease study 2019. Eur Spine J. 2023;32:590–600.

    Article  PubMed  Google Scholar 

  4. Elmelund M, Klarskov N, Biering-Sørensen F. Fecal incontinence and neurogenic bowel dysfunction in women with traumatic and nontraumatic spinal cord injury. Dis Colon Rectum. 2019;62:1095–104.

    Article  PubMed  Google Scholar 

  5. Jing Y, Yu Y, Bai F, Wang L, Yang D, Zhang C, et al. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome. 2021;9:59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jing Y, Yang D, Bai F, Wang Q, Zhang C, Yan Y, et al. Spinal cord injury-induced gut dysbiosis influences neurological recovery partly through short-chain fatty acids. NPJ Biofilms Microbiomes. 2023;9:99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Liu P, Liu M, Xi D, Bai Y, Ma R, Mo Y, et al. Short-chain fatty acids ameliorate spinal cord injury recovery by regulating the balance of regulatory T cells and effector IL-17(+) γδ T cells. J Zhejiang Univ Sci B. 2023;24:312–25.

    Article  PubMed  Google Scholar 

  8. Zhang D, Jian YP, Zhang YN, Li Y, Gu LT, Sun HH, et al. Short-chain fatty acids in diseases. Cell Commun Signal. 2023;21:212.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. He J, Zhang P, Shen L, Niu L, Tan Y, Chen L, et al. Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. Int J Mol Sci. 2020;21:6356.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yu B, Qiu H, Cheng S, Ye F, Li J, Chen S, et al. Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting. Bioengineered. 2021;12:4489–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kirshblum S, Snider B, Rupp R, Read MS. Updates of the international standards for neurologic classification of spinal cord injury: 2015 and 2019. Phys Med Rehabil Clin N Am. 2020;31:319–30.

    Article  PubMed  Google Scholar 

  12. van Doorn T, Groenendijk IM, Scheepe JR, Blok BFM. Neurogenic bowel dysfunction score in spinal cord-injured patients: translation and validation of the Dutch-language NBD score. Spinal Cord. 2022;60:223–7.

    Article  PubMed  Google Scholar 

  13. Pan Y, Liu B, Li R, Zhang Z, Lu L. Bowel dysfunction in spinal cord injury: current perspectives. Cell Biochem Biophys. 2014;69:385–8.

    Article  CAS  PubMed  Google Scholar 

  14. Pokusaeva K, Johnson C, Luk B, Uribe G, Fu Y, Oezguen N, et al. GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine. Neurogastroenterol Motil. 2017;29:e12904.

    Article  PubMed  Google Scholar 

  15. Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Oleskin AV, Shenderov BA. Probiotics and psychobiotics: the role of microbial neurochemicals. Probiotics Antimicrob Proteins. 2019;11:1071–85.

    Article  CAS  PubMed  Google Scholar 

  17. Panther EJ, Dodd W, Clark A, Lucke-Wold B. Gastrointestinal microbiome and neurologic injury. Biomedicines. 2022;10:500.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Path. 2017;13:e1006654.

    Article  Google Scholar 

  19. Kigerl KA, Hall JC, Wang L, Mo X, Yu Z, Popovich PG. Gut dysbiosis impairs recovery after spinal cord injury. J Exp Med. 2016;213:2603–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zhang C, Zhang W, Zhang J, Jing Y, Yang M, Du L, et al. Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury. J Transl Med. 2018;16:353.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Wang SZ, Yu YJ, Adeli K. Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis. Microorganisms. 2020;8:527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hoving LR, Heijink M, van Harmelen V, van Dijk KW, Giera M. GC-MS analysis of short-chain fatty acids in feces, cecum content, and blood samples. Methods Mol Biol. 2018;1730:247–56.

    Article  CAS  PubMed  Google Scholar 

  23. Rodenhouse A, Talukder MAH, Lee JI, Govindappa PK, O’Brien M, Manto KM, et al. Altered gut microbiota composition with antibiotic treatment impairs functional recovery after traumatic peripheral nerve crush injury in mice: effects of probiotics with butyrate producing bacteria. BMC Res Notes. 2022;15:80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zheng Y, Zhou X, Wang C, Zhang J, Chang D, Zhuang S, et al. Effect of dendrobium mixture in alleviating diabetic cognitive impairment associated with regulating gut microbiota. Biomed Pharmacother. 2022;149:112891.

    Article  CAS  PubMed  Google Scholar 

  25. Li R, Liu R, Chen L, Wang G, Qin L, Yu Z, et al. Microbiota from exercise mice counteracts high-fat high-cholesterol diet-induced cognitive impairment in C57BL/6 mice. Oxid Med Cell Longev. 2023;2023:2766250.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Szczesniak O, Hestad KA, Hanssen JF, Rudi K. Isovaleric acid in stool correlates with human depression. Nutr Neurosci. 2016;19:279–83.

    Article  CAS  PubMed  Google Scholar 

  27. Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linløkken A, Wilson R, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26:1155–62.

    Article  CAS  PubMed  Google Scholar 

  28. Gungor B, Adiguzel E, Gursel I, Yilmaz B, Gursel M. Intestinal microbiota in patients with spinal cord injury. PLoS One. 2016;11:e0145878.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Schmidt EKA, Torres-Espin A, Raposo PJF, Madsen KL, Kigerl KA, Popovich PG, et al. Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats. PLoS One. 2020;15:e0226128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kigerl KA, Mostacada K, Popovich PG. Gut microbiota are disease-modifying factors after traumatic spinal cord injury. Neurotherapeutics. 2018;15:60–67.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the Department of Spinal and Neural Functional Reconstruction, Beijing Bo’ai Hospital, China Rehabilitation Research Center, for their generous support. They are grateful to the Department of Emergency, Beijing Bo’ai Hospital, China Rehabilitation Research Center, for their help.

Funding

This study was supported by the Beijing Bo’ai Hospital.

Author information

Authors and Affiliations

Authors

Contributions

Dejian Zhang and Run Peng contributed equally to this work. Dejian Zhang conducted the search, collected and extracted the data, and wrote the manuscript. Run Peng extracted and analyzed the data, interpreted the results, and wrote the manuscript. Degang Yang extracted and analyzed the data.

Corresponding author

Correspondence to Degang Yang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

This study was approved by the Beijing Bo’ai Hospital Clinical Trial Organization Ethics Committee. The protocol for this clinical trial is registered (registration no. ChiCTR-RPC-17010621) and is available in full at the Chinese Clinical Trial Registry (https://www.chictr.org.cn/). Informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, D., Peng, R. & Yang, D. A preliminary study on the changes of fecal short chain fatty acids in patients with traumatic spinal cord injury in the chronic phase. Spinal Cord Ser Cases 11, 3 (2025). https://doi.org/10.1038/s41394-025-00698-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41394-025-00698-x

Search

Quick links